Mode
Text Size
Log in / Sign up
Phase 2 Completed N=38 Randomized Treatment

Pharmacokinetics Of Azithromycin Immediate Release And Extended Release Formulation In Kids With Acute Otitis Media

Source: ClinicalTrials.gov NCT00796224 ↗
Enrolled (actual)
38
Serious AEs
0.0%
Results posted
Jan 2010
Primary outcomePrimary: Area Under the Curve From Time Zero to 72 Hours (AUC72Hours) — 12173.023; 7950.949 ng*hr/ml

Summary

The purpose of this study was to determine the pharmacokinetics (PK), safety and clinical response following a single dose of either 30 mg/kg IR (Immediate Release) or 60 mg/kg ER (Extended Release) formulation in pediatric subjects 6 months to 6 years of age inclusive.

Outcome Measures

OutcomeResultp-value
PRIMARY
Area Under the Curve From Time Zero to 72 Hours (AUC72Hours)
12173.023; 7950.949
SECONDARY
Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUC Inf)
15536.196; 9645.630
SECONDARY
Maximum Observed Plasma Concentration (Cmax) of Azithromycin
774.750; 901.644
SECONDARY
Time to Reach Maximum Observed Plasma Concentration (Tmax) and Plasma Decay Half Life (t1/2) of Azithromycin
3.0; 2.0; 30.303; 28.959
SECONDARY
Serum Concentrations of Azithromycin ER (Test) and Azithromycin IR (Reference)
99.96; 152.75; 293.14; 579.72; 381.96; 381.69
SECONDARY
Number of Participants With a Clinical Response
18; 16; 0; 2
SECONDARY
Adverse Events (AEs) and Serious AEs (SAEs)
4; 5; 0; 0

Eligibility Criteria

Inclusion Criteria

  • Subjects age 6 months to < 12 years.
  • Have clinical signs/symptoms of acute otitis media in at least one ear.
  • Parent(s)/legal guardian(s) provide written informed consent.

Exclusion Criteria

  • Clinical significant other disease.
  • Recent use of investigational drugs, prescription or nonprescription drugs.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00796224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search